JOHANNESBURG (Reuters) - South African drug maker Adcock Ingram said a $1.2 billion takeover by Chile's CFR Pharmaceuticals, which is opposed by its biggest shareholder, was vital to its long-term survival. State pension fund Public Investment Corporation (PIC) is opposing CFR's cash-and-shares offer because of concerns about foreign control and the share component of the deal, a source familiar with the fund's thinking said earlier this month. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment